Yüksel Ürün

46PUBLICATIONS
144CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Aug 18, 2026
Global Real-World Outcomes of Olaparib in Metastatic Castration-Resistant Prostate Cancer Patients With Homologous Recombination Repair Alterations.

|Jul 15, 2026
Pretreatment HALP Score and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: A Turkish Oncology Group Kidney Cancer Consortium (TKCC) Study.

|May 03, 2026
Insights and Limitations in Evaluating Testosterone Recovery With LHRH Antagonists and Agonists.

|Mar 26, 2026
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).

Erman Akkus, Mehmet Kayaalp, Müzeyyen Aslı Ergözoğlu

|Mar 19, 2026
Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors.

Mustafa Gürbüz, Deniz Tural, Timuçin Çil

|Feb 25, 2026
Imposter Syndrome, Burnout, and Maladaptive Perfectionism Among Oncology Professionals: A Global Cross-Sectional Study.

Enes Erul, Vilma Pacheco-Barcia, Ali Alkan

Pageof 8

Frequent Collaborators

13 joint publications

Emre Yekedüz

7 joint publications

Hatime Arzu Yaşar

7 joint publications

Güngör Utkan

6 joint publications

Hatice Bolek